Carregant...

Pivotal Studies of Orphan Drugs Approved for Neurological Diseases

OBJECTIVE: To identify design elements of clinical trials leading to US Food and Drug Administration approval of drugs for neurological diseases with and without orphan indications. METHODS: We used publicly available information to identify approvals for drugs for neurological diseases with an orph...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Mitsumoto, Jun, Dorsey, E. Ray, Beck, Christopher A., Kieburtz, Karl, Griggs, Robert C.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3785304/
https://ncbi.nlm.nih.gov/pubmed/19743448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.21676
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!